A new thesis from Karolinska Institutet advocates end-of-life care that prioritizes the highest possible quality of life, avoids unnecessary or preventable risks and respects patient wishes.
Oct 31, 2023
0
126
Step aside, $3,500 Cartier watches and $12,000 Birkin bags. The latest status symbol may be full-body MRI scans, touted by celebrities such as Kim Kardashian and designer Zac Posen.
Sep 22, 2023
0
115
In a promising form of immunotherapy known as CAR T-cell (chimeric antigen receptor) therapy, the patient's T cells are engineered to better recognize and attack antigens on the surface of cancer cells. In treatments currently ...
Jul 27, 2023
0
44
A research team led by New Biology Professor Minseok Kim at the DGIST has developed a natural killer (NK) cell therapy product, which can self-activate with CT Cells. This new product has overcome the drawbacks of existing ...
Jul 5, 2023
0
73
Research published in Nature Communications today, has shown that techniques initially developed for astronomy and ecology can be used to study the microenvironment of solid tumors.
May 15, 2023
0
93
SpaceMarkers, a new machine learning software developed by researchers at the Johns Hopkins Convergence Institute and the Johns Hopkins Kimmel Cancer Center, can identify molecular interactions among distinct types of cells ...
May 11, 2023
0
61
Although chimeric antigen receptor (CAR) T cell therapy has shown potential in the treatment of hematological malignancies, its application in solid tumors is unsatisfactory due to the harsh physical barriers and immunosuppressive ...
Mar 15, 2023
0
79
Chimeric Antigen Receptor-expressing T cell (CAR-T) therapy involves re-engineering specific immune cells called T cells to target cancer. The treatment involves the production of CAR-T cells from the patient's own cells, ...
Feb 2, 2023
0
81
Teaching the body's immune cells to recognize and fight cancer is one of the holy grails in medicine. Over the past two decades, researchers have developed new immunotherapy drugs that stimulate a patient's immune cells to ...
Dec 16, 2022
0
101
An interdisciplinary team of researchers led by Indiana University bioengineer Feng Guo has developed a tool that could lead to improved cancer immunotherapy. The prototype platform facilitates automated drug screening and ...
Dec 1, 2022
0
100
